Chemung Financial (CMHG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for June 3, 2025, to be held virtually, with shareholders able to vote online, by phone, mail, or at the meeting.
Four main proposals: election of four directors, advisory vote on executive compensation (Say-on-Pay), approval of the 2025 Equity Incentive Plan, and ratification of Crowe LLP as external auditor.
Board recommends voting FOR all proposals; proxy materials are available online, with paper copies upon request.
Voting matters and shareholder proposals
Proposal 1: Elect four directors for three-year terms expiring in 2028; nominees are Ronald M. Bentley, David M. Buicko, Robert H. Dalrymple, and Jeffrey B. Streeter.
Proposal 2: Advisory approval of 2024 executive compensation; Board recommends FOR.
Proposal 3: Approval of 2025 Equity Incentive Plan, replacing the 2021 plan; Board recommends FOR.
Proposal 4: Ratification of Crowe LLP as independent auditor for 2025; Board recommends FOR.
No additional shareholder proposals will be considered at the meeting; deadlines for 2026 proposals are specified.
Board of directors and corporate governance
Board consists of 13 members, divided into three classes, with regular refreshment and diversity of experience.
Board leadership is separated between CEO and Chairman; majority of directors are independent.
Three standing committees: Audit, Nominating and Governance, and Compensation and Personnel, all composed of independent directors.
Annual review of strategic planning and governance standards; directors retire at 75 unless waived.
Latest events from Chemung Financial
- Record quarterly net income and improved efficiency driven by loan growth and strategic expansion.CMHG
Q1 202617 Apr 2026 - Robust loan growth, margin expansion, and capital strength drive continued strategic momentum.CMHG
Investor presentation10 Apr 2026 - All proposals passed; strong 2023 results, expansion, and dividends highlighted.CMHG
AGM 202431 Jan 2026 - Annual non-GAAP net income rose 17.8% to $27.9M, driven by strong loan growth and margin gains.CMHG
Q4 202526 Jan 2026 - Virtual meeting to elect directors, approve pay, equity plan, and auditor ratification.CMHG
Proxy Filing2 Dec 2025 - All proposals, including director elections and compensation, were approved by majority vote.CMHG
AGM 202526 Nov 2025 - Q3 net income up 36% year-over-year, with strong loan growth and improved margins.CMHG
Q3 20256 Nov 2025 - Net income declined 21% year-over-year as margin pressure persisted, but capital and lending improved.CMHG
Q2 20249 Oct 2025 - Adjusted net income reached $6.3M as capital moves offset a $17.5M securities loss.CMHG
Q2 20257 Aug 2025